Sign in

NCT07884032Not yet recruiting

Expression Intensity Modulates Social Intention Understanding in ASD Children

Expression Intensity Modulates Social Intention Understanding in Children With Autism Spectrum Disorder: Evidence From Eye Tracking and Functional Near-Infrared Spectroscopy

Source: ClinicalTrials.gov · Last updated 20 Oct 2026

Brief summary (registry, in English)

Children watch videos of a single model playing with toys, judge whether the model desires a new toy based on observing the model's varying expression intensities, and form a judgment on whether the model intends to obtain a new toy or not. During this process, children's eye-tracking data are recorded, and changes in blood oxygen levels in the cerebral cortex are captured via functional near-infrared spectroscopy (fNIRS) equipment. This study discusses children's social attention and the corresponding neural mechanisms during the intention understanding process.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
90 (estimated)
First submitted
8 Oct 2026
Start date
10 Oct 2026
Primary completion date
10 Dec 2026
Lead sponsor
University of Electronic Science and Technology of China
Diseases
Autism
NCT number
NCT07884032

What you commit to

  • Study type: Observational
  • Planned participants: 90
  • From 10 Oct 2026 to the primary completion date, 10 Dec 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Failure to meet the study's group-specific screen cutoffs on the Social Responsiveness Scale (SRS) and ADOS-2.
  • Known genetic syndromes.
  • Uncorrectable visual impairment.

Other

  • Significant hearing loss.

Who the study is looking for

  • For the TD group: Typically developing children without any developmental or neurological disorders.
  • For the ASD group: Confirmed clinical diagnosis of Autism Spectrum Disorder (ASD) and reconfirmed by the criteria of the Diagnostic Observation Table for ASD, Second Edition (ADOS-2).
  • For the ID group: Confirmed clinical diagnosis of Intellectual Disability (ID) and the ADOS-2 with a comparison score below the ASD diagnostic cut-off score (comparison score ≤ 2).
  • All groups: Normal or corrected-to-normal vision, no color vision deficiencies.
  • All groups: Legal guardian provided written informed consent.

Age in the registry: 5 years to 8 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.